Adicet bio to participate in upcoming investor conferences

Menlo park, calif., may 18, 2021 (globe newswire) -- adicet bio, inc. (nasdaq: acet), a biotechnology company discovering and developing allogeneic gamma delta t cell therapies for cancer and other diseases, today announced that company management will participate in two upcoming virtual investor conferences in may and june.
ACET Ratings Summary
ACET Quant Ranking